Re: The Impact of Bleomycin on Retroperitoneal Histology at Post-Chemotherapy Retroperitoneal Lymph Node Dissection of Good Risk Germ Cell Tumors: K. C. Cary, J. A. Pedrosa, H. Z. Kaimakliotis, T. A. Masterson, L. H. Einhorn and R. S. Foster J Urol 2015;193:507-512

J Urol. 2015 Jul;194(1):266; author reply 266. doi: 10.1016/j.juro.2015.01.103. Epub 2015 Apr 7.

Authors

Amit Verma¹, Vikas Giri¹, Shivam Priyadarshi¹

Affiliation

¹ Department of Urology, Sawai Man Singh Medical College and Hospital, Jaipur, Rajasthan, India.

PMID: 25857530
DOI: 10.1016/j.juro.2015.01.103

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibiotics, Antineoplastic / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Bleomycin / therapeutic use*
Humans
Lymph Node Excision*
Male
Neoplasms, Germ Cell and Embryonal / drug therapy*
Neoplasms, Germ Cell and Embryonal / surgery*
Retroperitoneal Space / pathology*
Testicular Neoplasms / drug therapy*
Testicular Neoplasms / surgery*

Substances

Antibiotics, Antineoplastic
Bleomycin